98-15686. Evaluation of Violence Prevention Programs for High-Risk Youth  

  • [Federal Register Volume 63, Number 113 (Friday, June 12, 1998)]
    [Notices]
    [Pages 32217-32219]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-15686]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [Program Announcement 98070]
    
    
    Evaluation of Violence Prevention Programs for High-Risk Youth
    
    A. Purpose
    
        The Centers for Disease Control and Prevention (CDC) announces the 
    availability of fiscal year (FY) 1998 funds for a cooperative agreement 
    program for the Evaluation of Violence Prevention Programs. This 
    program addresses the ``Healthy People 2000'' priority area of Violent 
    and Abusive Behavior.
        The purpose of this cooperative agreement is to support the 
    implementation and evaluation of interventions which are designed to 
    prevent violence-related injuries among high-risk youth (ages 13-21). 
    For the purpose of this announcement, high-risk youth does not include 
    youth that are detained.
        Applicants may propose to implement and evaluate interventions to 
    prevent injuries due to interpersonal youth (ages 13-21) violence. The 
    aim for these interventions is to reduce the risk of violence related 
    injury among high-risk youth and refers to impact assessment of efforts 
    to target youths (ages 13-21) who are in alternative schools, or have 
    been injured in a violent incident or have received treatment for a 
    violence related assault or trauma.
    
    B. Eligible Applicants
    
        Applications may be submitted by public and private nonprofit 
    organizations and by governments and their agencies; that is, 
    universities, colleges, research institutions, hospitals, other public 
    and private nonprofit organizations, and State and local governments or 
    their bona fide agents.
    
        Note: Pub. L. 104-65, which became effective January 1, 1996, 
    states that an organization described in section 501(c)(4) of the 
    Internal Revenue Code of 1986 which engages in lobbying activities 
    shall not be eligible to receive Federal funds constituting an 
    award, grant (cooperative agreement), contract, loan, or any other 
    form.
    
    C. Availability of Funds
    
        Approximately $1,500,000 is available in FY 1998 to fund 
    approximately four awards. It is expected that the average award will 
    be $375,000 ranging from $350,000 to $400,000. It is expected that the 
    awards will begin on or about September 30, 1998 and will be made for a 
    12-month budget period within a project period of up to three years. 
    Funding estimates may change.
        Non-competing continuation awards for new budget periods within an 
    approved project period are made on the basis of satisfactory 
    performance and availability of funds.
    
    Funding Preferences
    
        In making awards, priority consideration will be given to ensuring 
    geographic balance, a representative mixture of target groups, 
    diversity of intervention strategies, and settings. Priority will be 
    given to proposed projects evaluating efforts to reduce risk of 
    violence related injury among high-risk youth.
    
    D. Cooperative Activities
    
        In conducting activities to achieve the purpose of this program, 
    the recipient will be responsible for the activities under A. 
    (Recipient Activities), and CDC will be responsible for the activities 
    listed under B. (CDC Activities).
    1. Recipient Activities
        a. Develop and implement an intervention protocol.
        b. Develop and pilot test data collection instruments.
        c. Analyze data and interpret findings.
        d. Establish an advisory committee (who represents the target 
    population) that will address issues related to violence to ensure 
    community engagement.
        e. Develop collaborative relationships with voluntary, community-
    based public and private organizations and agencies already involved in 
    preventing violence.
        f. Compile and disseminate the results from the project.
    2. CDC Activities
        a. Collaborate on the development of the intervention protocol.
        b. Provide technical assistance on the development and evaluation 
    of the data collection instruments.
        c. Provide up-to-date scientific information about youth violence 
    prevention.
        d. Assist in the transfer of information and methods developed in 
    these projects to other prevention programs.
    
    E. Application Content
    
        Use the information in the Cooperative Activities, Other 
    Requirements, Evaluation Criteria sections and the Errata Sheet 
    (Addendum III), included in the application package to develop the 
    application content. Your application will be evaluated on the criteria 
    listed, so it is important to follow them in laying out your program 
    plan.
        The narrative should be no more than 30 double-spaced pages, 
    printed on one side, with one inch margins, and unreduced font (no 
    smaller than 10 cpi).
    
    F. Submission and Deadline
    
        Submit the original and five copies of PHS-398 (OMB Number 0925-
    0001) and adhere to the instructions on the Errata Instruction Sheet 
    for PHS 398. Forms are in the application kit.
        On or before AUGUST 13, 1998, submit to: Joanne Wojcik, Grants 
    Management Specialist, Grants Management Branch, Procurement and Grants 
    Office, Announcement 98070, Centers for Disease Control and Prevention 
    (CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E-13, 
    Atlanta, GA 30305-2209.
        If your application does not arrive in time for submission to the 
    independent review group, it will not be considered in the current 
    competition unless you can provide proof that you mailed it on or 
    before the deadline (i.e., receipt from U.S. Postal Service or a 
    commercial carrier; private metered postmarks are not acceptable).
    
    G. Evaluation Criteria
    
        Each application will be evaluated individually against the 
    following criteria by an independent reviewer group appointed by CDC. 
    Applicants will be evaluated according to the following criteria 
    (Maximum of 100 total points):
    1. Intervention Plan (35 Points)
        a. Target Group. The extent to which the target group is described 
    and access to the target population is demonstrated. The extent to 
    which the target group has a high incidence or prevalence of the risk 
    factors to be influenced by the proposed intervention and the extent to 
    which appropriate demographic and morbidity data are described. The 
    extent to which youth, who are the direct or indirect target group, 
    have a high incidence of interpersonal violence and violence-related 
    injuries, disabilities, and deaths. The extent to which the applicant 
    demonstrates a capability to achieve a sufficient level of 
    participation by the target group in order to evaluate the intervention 
    in an
    
    [[Page 32218]]
    
    unbiased fashion. In addition, the degree to which the applicant has 
    met the CDC/Agency for Toxic Substances and Disease Registry (ATSDR) 
    policy requirements regarding the inclusion of women, ethnic, and 
    racial groups in the proposed project. This includes:
        i. The proposed plan for the inclusion of both sexes and racial and 
    ethnic minority populations for appropriate representation.
        ii. The proposed justification when representation is limited or 
    absent.
        iii. A statement as to whether the design of the study is adequate 
    to measure differences when warranted.
        iv. A statement as to whether the plans for recruitment and 
    outreach for study participants include the process of establishing 
    partnerships with community(ies) and recognition of mutual benefits.
        b. Intervention description. The extent to which the potential 
    effectiveness of the intervention is theoretically justified and 
    supported by epidemiologic, or social and behavioral research. The 
    extent to which the intervention is feasible and can be expected to 
    produce the expected results in the target group of interest. The 
    extent to which the intervention, its implementation, the development 
    of all necessary materials, and all necessary training are clearly 
    described. The extent to which the desired outcomes (e.g., behavioral 
    change, avoidance/prevention of injury, disability, or death) are 
    specified and definitions of measurable endpoints are provided. The 
    extent to which the setting in which the intervention is to be 
    implemented is clearly described and shown to be adequate for reaching 
    the target group and achieving the desired objectives. The status of 
    all necessary measurement instruments or training materials must be 
    described; if any of this material is not extant, methods and time 
    frames for their development must be described. Necessary collaborators 
    must be identified, and evidence of their ability and intention to 
    participate must be supplied. The extent to which the proposed goals 
    and objectives are clearly stated, time-phased, and measurable.
    2. Evaluation Design and Analysis (35 Points)
        The extent to which the evaluation design and the data analysis 
    plan are clearly described and are appropriate for the target group, 
    intervention, data collection opportunities, and proposed project 
    period. The extent to which the various threats to the validity of the 
    evaluation are recognized and addressed. The extent to which the 
    sampling methods, sample size estimates, power estimates, and attrition 
    of the participating population are clarified. The extent to which data 
    collection, data processing, and management activities are clearly 
    described. The extent to which the major phases of the project are 
    clearly presented and logically and realistically sequenced. The extent 
    to which the proposed goals and objectives are clearly stated, time-
    phased, and measurable.
    3. Project Management and Staffing Plan (10 Points)
        The extent to which project management staff and their working 
    partners are clearly described, appropriately assigned, and possess 
    pertinent skills and experiences to conduct the project successfully to 
    completion. The extent to which the applicant has arranged to involve 
    appropriate researchers and other personnel who reflect the racial/
    ethnic composition of the target group. The extent to which the 
    applicant or a full working partner demonstrates the capacity and 
    facilities to design, implement, and evaluate the proposed 
    intervention.
    4. Collaboration (20 Points)
        The extent to which the necessary partners are clearly described 
    and their qualifications and intentions to participate explicitly 
    stated. The extent to which the applicant provides proof of support 
    (e.g., letters of support and/or memoranda of understanding) for 
    proposed activities. The extent to which a full working partnership 
    between a community-based organization, a university or other academic 
    institution, and a State or local health department has been 
    established for applicants seeking funds for a 3 year project period. 
    Evidence must be provided that these funds do not duplicate already 
    funded components of ongoing projects.
    5. Human Subjects (Not Scored)
        If human subjects will be involved, how they will be protect, i.e., 
    describe the review process which will govern their participation.
    6. Proposed Budget (Not Scored)
        The extent to which the budget request is clearly explained, 
    adequately justified, reasonable, sufficient for the proposed project 
    activities, and consistent with the intended use of the cooperative 
    agreement funds. Budgets should include costs for travel for two 
    project staff to attend two meetings per year in Atlanta with CDC 
    staff.
    
    H. Other Requirements
    
    1. Technical Reporting Requirements
        Provide CDC with an original plus two copies of:
        a. Semi-annual progress reports.
        b. Financial status report, no more than 90 days after the end of 
    the budget period.
        c. Final financial status report and performance report, no more 
    than 90 days after the end of the project period.
        Send all reports to: Joanne Wojcik, Grants Management Specialist, 
    Grants Management Branch, Procurement and Grants Office, Centers for 
    Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., 
    Room 300, Mailstop E-13, Atlanta, GA 30305-2209.
    
    Confidentiality of Records
    
        All identifying information obtained in connection with the 
    provision of services to any person in any program that is being 
    carried out with a cooperative agreement made under this announcement 
    shall not be disclosed unless required by a law of a State or political 
    subdivision or unless written, voluntary informed consent is provided 
    by persons who received services.
        1. Nonpersonal identifying, unlinked information, which preserves 
    the individual's anonymity, derived from any such program may be 
    disclosed without consent:
        a. In summary, statistical, or other similar form, or
        b. For clinical or research purposes.
        2. Personal identifying information: Recipients of CDC funds who 
    must obtain and retain personal identifying information as part of 
    their CDC-approved work plan must:
        a. Maintain the physical security of such records and information 
    at all times;
        b. Have procedures in place and staff trained to prevent 
    unauthorized disclosure of client-identifying information;
        c. Obtain informed client consent by explaining the risks of 
    disclosure and the recipient's policies and procedures for preventing 
    unauthorized disclosure;
        d. Provide written assurance to this effect including copies of 
    relevant policies; and
        e. Obtain assurances of confidentiality by agencies to which 
    referrals are made.
        Assurance of compliance with these and other processes to protect 
    the confidentiality of information will be required of all recipients. 
    A Department of Health and Human Services (DHHS) certificate of 
    confidentiality may be required for some projects.
        The following additional requirements are applicable to this
    
    [[Page 32219]]
    
    program. For a complete description of each, see Addendum I (included 
    in the application kit).
    
    AR98-1  Human Subjects Requirements
    AR98-2  Requirements for Inclusion of Women and Racial and Ethnic 
    Minorities in Research
    AR98-9  Paperwork Reduction Act Requirements
    AR98-10  Smoke-Free Workplace Requirements
    AR98-11  Healthy People 2000
    AR98-12  Lobbying Restrictions
    AR98-13  Prohibition on Use of CDC Funds for Certain Gun Control 
    Activities
    
    I. Authority and Catalog of Federal Domestic Assistance Number
    
        This program announcement is authorized under Sections 391, 392, 
    393, and 394 [42 U.S.C. 280b, 280b-1, 280b-1a, and 280b-2] of the 
    Public Service Act, as amended. The Catalog of Federal Domestic 
    Assistance number is 93.136.
    
    J. Where To Obtain Additional Information
    
        The program announcement and application forms may be downloaded 
    from the Internet: www.cdc.gov (look under funding). You may also 
    receive a complete application kit by calling 1-888-GRANTS4. You will 
    be asked to identify the program announcement number and provide your 
    name and mailing address. A complete announcement kit will be mailed to 
    you.
        Please refer to Program Announcement 98070 when you request 
    information.
        If you have questions after reviewing the forms, for business 
    management technical assistance, contact: Joanne Wojcik, Grants 
    Management Specialist, Grants Management Branch, Procurement and Grants 
    Office, Announcement 98070, Centers for Disease Control and Prevention 
    (CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E-13, 
    Atlanta, GA 30305-2209, telephone (404) 842-6535, E-mail address 
    jcw6@cdc.gov.
        For program technical assistance, contact Wendy Watkins, Division 
    of Violence Prevention, National Center for Injury Prevention and 
    Control, Centers for Disease Control and Prevention (CDC), 4770 Buford 
    Highway, NE., Mailstop K-60, Atlanta, GA 30341-3724, telephone (770) 
    488-4646, E-mail address dmw7@cdc.gov.
    
        Dated: June 8, 1998.
    John L. Williams,
    Director, Procurement and Grants Office, Centers for Disease Control 
    and Prevention (CDC).
    [FR Doc. 98-15686 Filed 6-11-98; 8:45 am]
    BILLING CODE 4163-18-M
    
    
    

Document Information

Published:
06/12/1998
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
98-15686
Pages:
32217-32219 (3 pages)
Docket Numbers:
Program Announcement 98070
PDF File:
98-15686.pdf